Division of Quality of Life and Palliative Care, Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Division of Nursing Research, Department of Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.
JAMA Oncol. 2017 Sep 1;3(9):1214-1220. doi: 10.1001/jamaoncol.2017.0368.
Early palliative care integration for cancer patients is now touted as the optimal care model, yet significant barriers often prevent its implementation. A perceived barrier, especially for pediatric oncology patients, is the notion that patients and their families may not need or want palliative care involvement early in the disease trajectory.
To determine the perception of symptom burden early in treatment and assess attitudes toward early integration of palliative care in pediatric oncology patient-parent pairs.
DESIGN, SETTING, AND PARTICIPANTS: Novel but pretested survey tools were administered to 129 patient-parent dyads of hospital-based pediatric oncology ambulatory clinics and inpatient units between September 2011 and January 2015. All patient participants were aged between 10 and 17 years and were diagnosed as having an oncologic condition 1 month to 1 year before enrollment. Both the patient and the parent in the dyad spoke English, and all participating parents provided written informed consent. A convenience sample was used for selection, with participants screened when otherwise presenting at a participating site. A total of 280 eligible participants were approached for study inclusion, 258 of whom were enrolled in the study (92.1% positive response-rate).
Degree of perceived suffering from early symptom-related causes, attitudes toward early palliative care integration, and patient-parent concordance. Statistical analysis included descriptive statistics, calculation of concordance, McNemar test results, and Cochran-Armitage trend test results.
Of the 129 patients in the dyads, 68 were boys, and 61 girls; of the 129 parents, 15 were men, and 114 women. Patients reported the following symptoms in the first month of cancer therapy: nausea (n = 109; 84.5%), loss of appetite (n = 97; 75.2%), pain (n = 96; 74.4%), anxiety (n = 77; 59.7%), constipation (n = 69; 53.5%), depression (n = 64; 49.6%), and diarrhea (n = 52; 40.3%). A large proportion of those reporting suffering indicated substantial suffering severity from specific symptoms (ie, a great deal or a lot) including nausea, 52.3% (57 of 109), loss of appetite, 50.5% (49 of 97), constipation 30.4% (21 of 69), pain 30.2% (29 of 96), anxiety 28.6% (22 of 77), depression 28.1% (18 of 64), and diarrhea 23.1% (12 of 52). Few children and parents expressed opposition to early palliative care involvement (2 [1.6%] and 8 [6.2%]) or perceived any detrimental effects on their relationship with their oncologist (6 [4.7%] and 5 [3.9%]), loss of hope (3 [2.3%] and 10 [7.8%]), or therapy interference (3 [2.3%] and 2 [1.6%], respectively). Intradyad concordance was low overall: 26% to 29% for exact concordance and 40% to 69% for agreement within 1 response category. Significant differences in patient-parent attitudes toward aspects of early palliative care included child participants being more likely than their parents (40.3% [n = 52] vs 17.8% [n = 23]) to indicate that palliative care would have been helpful for treating their symptoms (P < .001).
Pediatric oncology patients experience a high degree of symptom-related suffering early in cancer therapy, and very few patients or parents in this study expressed negative attitudes toward early palliative care. Our findings suggest that pediatric oncology patients and families might benefit from, and are not a barrier to, early palliative care integration in oncology.
现在,癌症患者的早期姑息治疗被吹捧为最佳护理模式,但仍存在许多阻碍其实施的因素。一个被认为的障碍,特别是对于儿科肿瘤患者,是患者及其家属在疾病早期可能不需要或不希望参与姑息治疗的观念。
确定在治疗早期的症状负担感知,并评估在儿科肿瘤患者-家长对子中早期整合姑息治疗的态度。
设计、设置和参与者:2011 年 9 月至 2015 年 1 月期间,在基于医院的儿科肿瘤门诊和住院病房的 129 个患者-家长对子中使用了新颖但经过预先测试的调查工具。所有患者参与者的年龄在 10 至 17 岁之间,在入组前 1 个月至 1 年内被诊断患有肿瘤疾病。患者-家长对子中的患者和家长都讲英语,所有参与的家长都提供了书面知情同意书。采用方便抽样进行选择,当有参与者在参与地点就诊时,对其进行筛选。共有 280 名符合条件的参与者被邀请参加研究,其中 258 名被纳入研究(92.1%的积极响应率)。
感知到的与早期症状相关的痛苦程度、对早期姑息治疗整合的态度以及患者-家长的一致性。统计分析包括描述性统计、一致性计算、McNemar 检验结果和 Cochran-Armitage 趋势检验结果。
在 129 对患者中,68 名是男孩,61 名是女孩;在 129 名家长中,15 名是男性,114 名是女性。患者在癌症治疗的第一个月报告了以下症状:恶心(n=109;84.5%)、食欲不振(n=97;75.2%)、疼痛(n=96;74.4%)、焦虑(n=77;59.7%)、便秘(n=69;53.5%)、抑郁(n=64;49.6%)和腹泻(n=52;40.3%)。报告有痛苦的患者中,很大一部分患者表示特定症状的严重程度很大(即非常多或很多),包括恶心 52.3%(57/109)、食欲不振 50.5%(49/97)、便秘 30.4%(21/69)、疼痛 30.2%(29/96)、焦虑 28.6%(22/77)、抑郁 28.1%(18/64)和腹泻 23.1%(12/52)。很少有儿童和家长表示反对早期姑息治疗的参与(2[1.6%]和 8[6.2%])或认为这会对他们与肿瘤医生的关系产生任何不利影响(6[4.7%]和 5[3.9%])、失去希望(3[2.3%]和 10[7.8%])或治疗干扰(3[2.3%]和 2[1.6%])。总体而言,患者-家长之间对早期姑息治疗的态度一致性较低:完全一致的比例为 26%至 29%,在 1 个回答类别内一致的比例为 40%至 69%。在早期姑息治疗的各个方面,儿童患者与家长的态度存在显著差异,儿童患者比家长更有可能表示姑息治疗对治疗他们的症状会有所帮助(40.3%[n=52]比 17.8%[n=23])(P<.001)。
儿科肿瘤患者在癌症治疗的早期经历了高度的与症状相关的痛苦,在这项研究中,很少有患者或家长对早期姑息治疗持负面态度。我们的研究结果表明,儿科肿瘤患者及其家属可能受益于早期姑息治疗的整合,并且不会成为肿瘤学中早期姑息治疗的障碍。